On the other hand, some cancers previously taken into consideration for screening for BRCA1/2 carriers, like melanoma, may be reconsidered, to further optimize cancer prevention screening strategies and eventually reduce carriers' distress. This evidence concerns the gene BRCA1 and melanoma.